Trastuzumab Deruxtecan
Daiichi Sankyo,AstraZeneca
['surf', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'rux,(-crux),(-trux)', 'destiny,crc,02', 'trastuzumab deruxtecan']
luke, it is your destiny ... to check her2 status in mcrc and treat accordingly presents destiny-crc02 at #asco23 with an orr ~ 40% with trastuzumab deruxtecan at 5.4mg/kg, surfacing it as the optimal dose in terms of risk/benefit #crcsm 
Director, GI Oncology, @Intermountain. Interests: neuroendocrine tumors, cancer syndromes, empathy (even had a Whipple myself). Tweets my own.